Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02217787Phase 1Completed
Phase 1, randomised, open-label trial of darigabat in epilepsy and generalized anxiety disorder (GAD) (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time at 48 hours, Area Under the Curve From Time Zero to Last Quantifiable Concentration at 48 hours and 3 more. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02217787.